Quenbo

Clinical pathologist - EuSpLM

[Quenbo @Quenbo79]

Hi @elonmusk @Tesla. Why does my TMS not remember the phone calls that don't succeed (android)? I just can see the last successful calls. So if I want to recall directly with the steer buttons it does not work? Am I doing it wrong? Or can you fix it? Thanks for your help!

[Shannon Stirone💀 @shannonmstirone]

Hey every science follower I have who is still awake, do me a favor and give me one reason why you think the Opportunity rover is worth saving, please use these hashtags #WakeUpOppy #SaveOppy.

[Labiotech.eu @Labiotech_eu]

It's getting closer! @CelyadSA #celltherapy #biotech https://t.co/XwQw3Zpluz

[Jacob Plieth @JacobPlieth]

What is this TCR-inhibitory molecule that could allow allogeneic cell therapy without gene editing? Via David Gilham $CYAD https://t.co/wnmL45TJso

[Keh Ke Peheno @coolfunnytshirt]

Neymar just sent a friend request to Mbappe..

[Jason Hughes @wk057]

Alright, @Tesla this is ridiculous. After the latest update autopilot asked me to hold the wheel *15 times in 8 minutes* on a clear highway stretch, regardless of actual hand location. This is now completely useless. 😡 #FindAnotherSolution @elonmusk

[bernard pivot @bernardpivot1]

Enfin une victoire de Bruxelles sur un paradis fiscal, Panama !

[Cancer Progress @CancerProgress]

Very clever construct by Celyad. #io360nyc #Immunotherapy #cancerresearch #CancerProgressbyDH

[Sacha Pouget @Sachakin]

Cet interview du CEO de Novartis est extra avec un regard lucide et une vision claire. Selon lui, l'oncologie et la thérapie génique sont les prochaines frontières scientifiques à franchir $ALCLS $CYAD https://t.co/HGy8DLFCHx

[US Banking News @AmericanBanking]

Zacks: Celyad SA $CYAD Given $74.00 Consensus Price Target by Analysts https://t.co/gBjeopKsi2 #stocks

[L'Echo @lecho]

Celyad, star de ce début 2018 https://t.co/uzWBtUVXjr

[Dr Christian Homsy @ChristianHomsy]

Congratulations to Lucia Fernandez et al. for yet another independent proof of concept of NKG2D activity, this time in osteosarcoma. https://t.co/yMhQK0p5vy.

[Edison @Edison_Inv_Res]

Revised Celyad strategy after clinically significant responses in AML and colorectal cancers indicates.. #CYAD https://t.co/QYuNWalKCU

[Sebastien 🇨🇵🇪🇺 @sebaast1n]

https://t.co/avU6QZuldz
Mis à jour objectif edison ->103 €
#celyad $cyad #biotech

[William Elliott @cells_nnm]

What is the hottest CAR cell therapy target beyond CD19? Here is the answer https://t.co/KFJOQmtu0l

[`((,(Dieter 'Hovekamp)))🇺🇦👥🤝👥🇷🇺 ☮️🕊️🌍🐬 @dhovekamp42]

@cells_nnm @bradloncar One interesting CAR-T target might outscore all others together (if it works) IMO is Sellmans NKG2D now with $CYAD https://t.co/Kn91oBsr2l

[Bertrand Delsuc @BertrandBio]

finally, it seems mgmt has 'promising' data to diclose furtherly for CRC/ovarian, multi-strat to tackle ST,nxt gen to↗️activity vs TME 8/8

[Bertrand Delsuc @BertrandBio]

few comments after Celyad $CYAD call today:AML patient w/MLFS classified as CRi (incomplete blood count recovery)&not CR but close to CR 1/n